Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Mar 22, 2022
Date Accepted: Mar 22, 2022

The final, peer-reviewed published version of this preprint can be found here:

Metadata Correction: Clinical Outcomes Among Working Adults Using the Health Integrator Smartphone App: Analyses of Prespecified Secondary Outcomes in a Randomized Controlled Trial

Bonn S, Licitra G, Bellocco R, Trolle Lagerros Y

Metadata Correction: Clinical Outcomes Among Working Adults Using the Health Integrator Smartphone App: Analyses of Prespecified Secondary Outcomes in a Randomized Controlled Trial

J Med Internet Res 2022;24(3):e38199

DOI: 10.2196/38199

PMID: 35324452

PMCID: 8990340

Metadata Correction: Clinical Outcomes Among Working Adults Using the Health Integrator Smartphone App: Analyses of Prespecified Secondary Outcomes in a Randomized Controlled Trial

  • Stephanie Bonn; 
  • Gabriella Licitra; 
  • Rino Bellocco; 
  • Ylva Trolle Lagerros

ABSTRACT

Placeholder abstract


 Citation

Please cite as:

Bonn S, Licitra G, Bellocco R, Trolle Lagerros Y

Metadata Correction: Clinical Outcomes Among Working Adults Using the Health Integrator Smartphone App: Analyses of Prespecified Secondary Outcomes in a Randomized Controlled Trial

J Med Internet Res 2022;24(3):e38199

DOI: 10.2196/38199

PMID: 35324452

PMCID: 8990340

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.